July 1, 2015
In a new study published in Annals of Internal Medicine, researchers found that Medicaid coverage restrictions for Sovaldi may not be allowing certain patients with hepatitis C virus infection to receive proper care.
“Federal Medicaid law requires coverage, yet reimbursement criteria for Medicaid programs effectively deny access,” Lynn E. Taylor, MD, director of the HIV/Viral Coinfection program at The Miriam Hospital in Providence, Rhode Island, said in a press release. “The denial of treatment by most states violates the spirit of the law. In our analysis, we found that most states with known sofosbuvir Medicaid reimbursement requirements impose undue restrictions on eligible recipients.”